ArticleOncotarget2015

MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1.

Shaohua Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.